TBC1D24 Antibodies

Santa Cruz Biotechnology delivers a wide array of TBC1D24 monoclonal antibodies for investigating TBC1D24's role in cellular processes. TBC1D24 Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TBC1D24 is a member of the TBC (Tre-2/Bub2/CDC16) domain family, which regulates Rab GTPase activity and plays a crucial role in intracellular trafficking and signaling pathways. Mutations in TBC1D24 have been linked to various neurological disorders, emphasizing its significance in neuronal function and development. Research focused on TBC1D24 continues to reveal new insights into cellular mechanisms and potential therapeutic approaches. Understanding TBC1D24's molecular interactions and regulatory functions can advance knowledge about neurological conditions. Investigating TBC1D24's role in different cellular pathways may uncover novel treatment strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TBC1D24 and its impact on human health.